AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2690-4861/430
1Suiyukai Clinic, Kashihara, Nara 634-0007, Japan.
2Department of Chemistry, Kurume University School of Medicine, Fukuoka 830 0011, Japan.
*Corresponding Author: Yoshihiro Motomiya, Suiyukai Clinic, Kashihara, Nara 634-0007, Japan.
Citation: Yoshihiro Motomiya, Yoshiteru Kaneko and Yuichiro Higashimoto, (2024), Clinical Usefulness of the serum-Soluble Transferrin Receptor in Iron Dysregulation Associated with long-Term Hemodialysis, International Journal of Clinical Case Reports and Reviews, 17(2); DOI:10.31579/2690-4861/430
Copyright: © 2024, Yoshihiro Motomiya. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 March 2024 | Accepted: 12 April 2024 | Published: 23 April 2024
Keywords: hemodialysis; iron dysregulation; soluble transferrin receptor; hepcidin
Background: Soluble transferrin receptor (sTfR) was reported to be a valuable diagnostic marker for iron dysregulation (ID). Hepcidin, which is a key regulator of iron metabolism, has been shown to have increased values in patients undergoing hemodialysis (HD). Either treatment with erythropoietin stimulating agent（ESA） or iron repletion therapy（IRT）had been reported to induce controversial effect on serum levels between sTfR and hepcidin. Thus, we measured serum levels both of sTfR and hepcidin in 97 HD patients and investigated the clinical value of these measures.
Methods: We used a commercial enzyme-linked immunosorbent assay kit to measure serum levels both of hepcidin and sTfR.
Results: Although serum sTfR levels did not clearly increase, both sTfR levels and its index value correlated with the saturation of transferrin, erythropoietin-stimulating agent dosage, and erythropoietin resistance index (ERI). In addition, a strong negative correlation was found for sTfR and log serum hepcidin values.
Conclusions: Serum sTfR levels and the sTfR index were acceptable markers for iron dysregulation (ID) and ERI even in patients undergoing HD whose serum levels of hepcidin increased.
Iron dysregulation (ID) is one of most common complications associated with patients undergoing long-term hemodialysis (HD). More than half of HD patients need treatment with an erythropoietin-stimulating agent (ESA), which leads to a greater iron demand because of enhanced erythropoiesis. In fact, most HD patients treated with an ESA had several kinds of iron repletion therapy (IRT). Thus, monitoring and modulation of the body’s iron status have become important routine works in HD. Iron metabolism in patients on maintenance HD is compromised by several factors including hepcidin. Hepcidin is generally acknowledged to be a key modulator in iron metabolism and reportedly increased in HD patients [1]. Hepcidin is mainly produced in hepatocytes and is known to degrade ferroportin on cell membranes, i.e. an exclusive exporter of intracellular iron. Although hepcidin was acknowledged to be a causative factor in ID associated with chronic inflammation [2, 3], its clinical significance has not been fully determined in the clinical setting described here, especially in patients undergoing ESA treatment and/or IRT.
In addition to hepcidin, a transferrin receptor (TfR) is a key regulator of iron, and its circulating levels have served as a marker for ID. A circulating TfR, i.e. soluble TfR (sTfR), is derived mainly from TfR1 expressed on cell membranes and is the main iron importer into cells, in contrast to ferroportin, which is an exporter. In addition, recent clinical studies indicated that the serum sTfR/log ferritin (Ft) ratio (sTfR index) was a useful index of ID [4–6]. However, the diagnostic significance of this index has not been fully studied in HD patients, whose serum levels of hepcidin are expected to be elevated.
In addition, both serum hepcidin and sTfR levels are likely to vary controversially according to the IRT and ESA treatment [8,15,17]. It thus seems important to understand the relationship between these two iron modulators in HD patients. In this study, we measured the serum levels of both hepcidin and sTfR in 97 HD patients, and we investigated their relationship with the patients’ iron status. In addition, we discussed the clinical usefulness of both serum sTfR levels and the sTfR index and the implications of hepcidin for these parameters.
Subjects
Ninety-seven patients, 52 male and 45 female, receiving maintenance HD and 16 healthy volunteers, 8 male and 8 female, were subjects in our study; all gave informed consent for participation. The mean ages (± standard error of the mean) of the patients and volunteers were 72.9 ± 10.5 (range 46–94) years old and 49.9 ± 8.3 (range 37–66) years old, respectively. Patients’ primary diseases included chronic kidney disease (CKD) plus non-diabetes mellitus diseases in 57 patients, and plus diabetes mellitus in 40 patients. The mean duration of dialysis was 119.8 ± 106.6 months. Sixty-six patients were undergoing regular HD three times a week, and 31 patients were undergoing online hemodiafiltration (HDF) three times a week.
The treatment index Kt/V is used to assess dialysis dose, and its mean values, according to a single-pool model, were 1.30 ± 0.29 in patients receiving regular HD and 1.36 ± 0.23 in patients receiving HDF (p = 0.327) [7].
Patients with active sign of inflammation, bowel hemorrhage or liver damage and patients freated with HIF PH inhibitor were excluded from this study.
At the start of HD on the first day of the week, we obtained blood samples via an arterial line. All parameters shown in Table 1 were measured by Falco Laboratory (Kyoto, Japan). Serum levels of bioactive hepcidin were measured at Kurume University by using commercial kits (DRG Instruments GmbH, Marburg, Germany), and serum levels of sTfR were measured similarly by using commercial kits (Abcam plc, Cambridge, UK).
ESA treatments and IRT
Three ESAs—epoetin beta, darbepoetin alfa, and epoetin beta pegol—were given to 82 patients. Each ESA dosage was converted to an epoetin beta unit according to previous reports, and the mean dosage was 74.86 ± 49.65 IU/kg body wt/W [8]. ERI values were calculated by using a formula as a weekly ESA dose/kg body wt/Hb [9]. The mean ERI value was 7.30 ± 5.34 (range 0.63–7.22). Forty-nine patients received IRT by means of saccharated ferric oxide (Fesin) (Nichi-Iko Pharmaceutical Co. Ltd., Tokyo), at mean dose of 1.678 ± 0.951 mg/kg/M.
Data were analyzed by student’s t test or Peason’s method using JMP version 9.0.0 (University of California, Merced, CA). Data are presented here as the mean ± standard error of the mean. A p value of less than 0.05 was considered to be statistically significant.
Basic laboratory data
Table 1 presents basic laboratory data of the study participants. The mean saturation of transferrin (TSAT) value was 29.4 ± 10.5% (13–69%), and the mean serum Ft concentration was 169.1 ± 121.7 ng/ml (17–602 ng/ml). No patient with C-reactive protein levels higher than 0.5 mg/dl was included. Abbreviation: ESRD, end-stage renal disease.
| Parameter | ESRD patients (n = 97) | Healthy volunteers (n = 16) |
|---|---|---|
| Albumin (g/dl) | 3.63 ± 0.32 | 4.46 ± 0.21 |
| Creatinine (mg/dl) | 10.3 ± 2.69 | 0.76 ± 0.16 |
| C-reactive protein (mg/dl) | 0.20 ± 0.30 | 0.04 ± 0.08 |
| Iron (μg/dl) | 70.9 ± 26.3 | 104.9 ± 27.0 |
| Ferritin (ng/dl) | 169.2 ± 122.3 | 73.4 ± 56.3 |
| TSAT (%) | 29.4 ± 10.5 | 30.4 ± 11.3 |
| Hepcidin (ng/ml) | 29.7 ± 26.0 | 9.8 ±5.8 |
| sTfR (ng/ml) | 1387.4 ± 599.3 | 1124.2 ± 370.9 |
Table 1: Basic laboratory data of study participants
Serum levels of hepcidin
Although 22 patients had low levels of serum hepcidin (<10>p = 0.003)—and these values showed a strong positive correlation with serum Ft values (r = 0.531, p < 0>p = 0.71). Serum hepcidin levels were, albeit not significant, higher in patients having IRT compared with levels in patients not having IRT (33.4 ± 25.7 vs. 25.9 ± 26.1 ng/ml, p = 0.157). Serum hepcidin levels were 29.3 ± 25.0 ng/ml in patients undergoing ESA therapy and 32.3 ± 32.0 ng/ml in those not undergoing ESA therapy (p = 0.69). No correlation could be confirmed between serum hepcidin levels and either ESA dosage or iron
dosage (data not shown). Also, no correlation was found between serum hepcidin levels and TSAT values or ERI values (data not shown).
Serum levels of sTfR
Serum sTfR levels were moderately higher in HD patients than in controls (1387.4 ± 599.3 vs. 1124.2 ± 370.9 ng/ml, p = 0.0919). No significant difference was seen in serum sTfR levels between the patient subgroup undergoing regular HD and that undergoing HDF (1428.4 ± 585.5 vs. 1300.0 ± 628.5 ng/ml, p = 0.328). In addition, no significant difference in serum sTfR levels was found for patient subgroups with and without IRT or with and without ESA therapy (1317.4 ± 519.8 ng/ml vs. 1458.9 ± 668.8 ng/ml; 1384.9 ± 547.4 ng/ml vs. 1401 ± 853.6 ng/ml, respectively). However, a good correlation existed between serum sTfR levels and ESA dosage (r = 0.348, p = 0.00136) (Figure. 1a).
Figure 1: Correlation between serum sTfR levels and ESA dose (a) and ERI (b). Abbreviation: rHuEPO, recombinant human erythropoietin.
Similarly, a good correlation was found between serum sTfR levels and ERI values (Figure. 1b). In addition, serum sTfR levels were inversely correlated with TSAT values (r = -0.27, p = 0.00743) (Figure. 2).
Figure 2: Correlation between TSAT and serum sTfR values.
Serum sTfR index Serum sTfR index values in HD patients were not significantly different from those in controls (304.8 ± 165 vs. 319.0 ± 153.9, p = 0.746). However, this index correlated strongly with TSAT values and with either ESA dosage or ERI (Figure. 3 and 4). No correlation was found between the sTfR index and the iron dosage (p = 0.877) (data not shown).
Figure 3: Correlation between TSAT and sTfR index.
Figure 4: Correlation between sTfR index and ESA dose (a) and ERI (b).
Correlation among parameters related to hepcidin and sTfR As expected from the converse effects of ESA therapy on serum levels of hepcidin and sTfR, a strong inverse correlation was found between hepcidin and both serum sTfR levels and the sTfR index (Figure. 5). In
particular, a correlation between the log serum hepcidin values and the sTfR index was confirmed with extremely high significance (r = 0.523, p < 0>
Figure 5: Correlation between serum hepcidin levels and serum sTfR values (a) and the sTfR index (b).
ID has been well-known as a common complication associated with CKD [10]. In addition, current ESA treatments in CKD patients increase the iron demand to respond to stimulated erythropoiesis. Consequently, most HD patients undergoing ESA treatment must have several types of IRT.
Thus, to minimize the generation of radical oxygen species caused by ferrotoxic action, iron dosages have been monitored according to the percent TSAT, with those values kept at roughly 20% or more. However, TSAT values may still be problematic as an index of ID in this clinical setting [11].
ID in HD patients is multifactorial and mostly complicated by chronic inflammation related to oxidative stress associated with long-term HD, which is believed to stimulate production of hepcidin via interleukin-6 in the liver [12, 13]. Hepcidin was believed to be a key factor in iron metabolism and to impair iron trafficking including mobilization from tissues into systemic circulation. Hepcidin was reportedly thought to be a causative factor of functional iron deficiency in HD patients [14].
Hepcidin production was also stimulated directly by iron loading [15] and conversely was suppressed directly by erythroferrone during ESA treatment, as reported previously [8]. In this study, we could not confirm significant differences in serum hepcidin levels among patient subgroups with vs. without IRT or ESA treatment, nor could we correlate serum hepcidin levels with TSAT, iron dosage, and ESA dosage. However, we believe that those treatments compromised a direct correlation among them and that hepcidin is a major causative factor in ID in HD patients as well as in other inflammatory diseases. In fact, a logarithmic transformed serum hepcidin level correlated strongly with the sTfR index, which is known as a marker for ID (Figure. 5b).
Serum sTfR levels reportedly increased exclusively in functional iron deficiency [16]. In addition, serum sTfR levels increased during ESA treatment [17]. However, in this study the sTfR levels did not increase as clearly as in reports of other anemic diseases associated with chronic inflammatory conditions [18]. Nevertheless, a significant negative correlation of TSAT was confirmed with either sTfR or the sTfR index, which suggests that those parameters are useful as markers for ID as reported previously [19, 20]. In particular, as reported earlier, the sTfR index seemed superior to serum sTfR levels, even in HD patients undergoing IRT, because of higher significance in Figure. 3, which indicated that the index of 800 corresponded to 20% of TSAT [21, 22].
Serum sTfR levels depend on the extent of expression of TfR1 on cell membranes, which is regulated by a hypoxia-inducible factor and an iron regulatory protein (IRP)/iron-responsive element (IRE) system. The IRP/IRE system function depends on cellular free iron levels [23, 24].
Hepcidin was reportedly excreted in urine [25], which means that serum hepcidin levels before HD were elevated in all patients with end-stage kidney disease. Thus, for iron loading when high hepcidin levels exist, such as in our patients, intracellular iron levels may increase via TfR and inactivate the IRP/IRE system, which would turn off translation of sTfR mRNA and turn on translation of Ft mRNA. As a consequence, an increase in sTfR associated with iron deficiency was thought to be likely offset by inactivated IRP during high levels of hepcidin.
In addition, TfR expression is most abundant in erythroblasts and has reportedly increased along with enhanced erythropoiesis after ESA treatment. We also found a correlation with ESA doses in this study, which suggests that both serum sTfR levels and the sTfR index are possible markers for ERI despite a coexisting increase in hepcidin [26]. We did confirm a good correlation between ERI and both serum sTfR levels and the sTfR index. ERI is determined mostly by a weekly dosage of ESA [9]so a correlation with the ESA dosage is likely to result in a correlation with ERI as well.
Belo et al. also recently demonstrated that serum sTfR levels were a suitable indicator of ERI in HD patients [17]. Our study thus suggested that the sTfR index may be a valuable marker for ERI as well as serum sTfR values (Figure. 4b). In addition, the sTfR index is expected to serve as an aid to monitor iron supplementation because of the lack of differences in basal levels compared with controls (Figure. 4b).
Finally, a negative correlation between serum levels of hepcidin and sTfR might be due to antagonistic effect on both IRT and ESA therapy on their serum levels rather than due to direct interaction with each other.
Our study showed that both serum sTfR levels and the sTfR index served as indicators of ID and ERI, but the clinical utility of these indicators was compromised by hepcidin, which was elevated by renal failure, subclinical inflammation associated with long-term HD, and iron loading. Although we could not provide direct proof of the involvement of hepcidin with ID, compared with TSAT, a logarithmic value of serum hepcidin levels correlated strongly with the sTfR index, which indicated strong implication of hepcidin with ID in HD patients. We therefore should not ignore the implications of hepcidin. Our study thus indicated a clinical value of sTfR in the diagnosis of ID even with high levels of serum hepcidin.
This study had several limitations. First, it was a cross-sectional study of 96 patients who were older than the control subjects. Next, our patients underwent two types of HD treatment, i.e. regular and online HDF. Last, blood was sampled only once at different times, including 7:30 AM, 12:30 PM, and 16:30 PM.
Ethics approval and consent to participate
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Suiyukai (protocol code 014, March 15th, 2019).
Not applicable
All data generated or analysed during this study are included in this published article [and its supplementary information files].
The authors declare that they have no other relevant financial interests.
The authors declare no competing interests.
Research idea and study design: YM,YK; data acquisition: YM, YH; data analysis/interpretation: YM, YK; statistical analysis: YH; supervision or mentorship: YM. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual’s own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
